FastWave Medical Gains FDA IDE Approval for Artero IVL
Minneapolis, Minnesota, August,11, 2026 FastWave Medical has received U.S. Food and Drug Administration (FDA) approval of its Investigational Device...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Minneapolis, Minnesota, August,11, 2026 FastWave Medical has received U.S. Food and Drug Administration (FDA) approval of its Investigational Device...
Kirkland, Washington, August,11, 2026 EIT Pharma, Inc. has announced that the U.S. Food and Drug Administration (FDA) has accepted...
Newton, Massachusetts, USA & Shefayim, Israel, August 10, 2026 AQUAPASS, Inc. has announced the completion of enrollment in its...
Mumbai, India & Naples, Florida, USA, August 10, 2026 Lupin Limited has announced that it has received U.S. Food...
Seoul, South Korea, August 10, 2026 Seegene Inc. has announced a comprehensive approach to syndromic PCR screening for reproductive...
San Francisco, California, USA, August 10, 2026 Avere Therapeutics, Inc. has announced a $500 million private placement from a...
Staten Island, New York, USA, August 10, 2026 Acurx Pharmaceuticals, Inc. has announced a new scientific partnership with Leiden...
Cambridge, Massachusetts, USA, August 8, 2026 Biogen has completed the acquisition of RayThera Inc., a privately held biotechnology company...
San Diego, California, USA, August 8, 2026 Blacksmith Medicines has announced the publication of new research in the Journal...
CAMBRIDGE, Mass., Aug. 5, 2026 Moderna, Inc. has received U.S. Food and Drug Administration (FDA) approval for mFLUSIVA® (mRNA-1010),...
